Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-041109

Chief Commercial Officer acquired 15,625 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Greco Theresa Chief Commercial Officer 2025-08-21 Grant or award +15,625 75,981 D
Derivatives
Greco Theresa Chief Commercial Officer 2025-08-21 Grant or award · Stock Option +35,156 35,156 D
Loading xslF345X05/wk-form4_1756149437.xml…